HRT Financial’s Microbot Medical MBOT Stock Holding History

HRT Financial’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-57,941	Closed	-$95K	–	2770
2023 Q4	$95K	Buy	+57,941	New	+$77.2K	﹤0.01%	1896

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's MBOT Position: Q1 2024 in Review

HRT Financial sold out of Microbot Medical (MBOT) in Q1 2024, closing a stake of 57,941 shares — an estimated $95K sold.

HRT Financial first reported a position in MBOT in Q4 2023 and held it in 1 quarter. The position peaked at $95K in Q4 2023. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2024.

HRT Financial reported no remaining Microbot Medical position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 57,941 Microbot Medical shares in Q1 2024, an estimated $95K.
HRT Financial first reported a position in Microbot Medical in Q4 2023 and held it in 1 quarter.
HRT Financial's Microbot Medical position peaked at $95K in Q4 2023.
33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.